ÖZDEMİR, E. Et Al. 2007. Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone. 49th Annual Meeting of the American-Society-of-Hematology , (Georgia, United States Of America).

ÖZDEMİR, E., Koc, Y., Kars, A., Turker, A., Tekuzman, G., & KANSU, E., (2007). Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone . 49th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America

ÖZDEMİR, EVREN Et Al. "Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone," 49th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 2007

ÖZDEMİR, EVREN Et Al. "Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone." 49th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America, 2007

ÖZDEMİR, E. Et Al. (2007) . "Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone." 49th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America.

@conferencepaper{conferencepaper, author={EVREN ÖZDEMİR Et Al. }, title={Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone}, congress name={49th Annual Meeting of the American-Society-of-Hematology}, city={Georgia}, country={United States Of America}, year={2007}}